July 30, 2016 12:18 PM ET


Company Overview of Exosome Diagnostics, Inc.

Company Overview

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. The company develops exosome-based diagnostics technology platform that harvests comprehensive and dynamic molecular information contained within exosomes from various fresh or frozen biofluids to deliver personalized healthcare to guide treatment decisions and in real-time along the entire patient care continuum. Its technology combines RNA analysis with DNA and protein analysis to deliver comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated, and monitored. The company al...

Riverside Technology Center

840 Memorial Drive

Suite 3

Cambridge, MA 02139

United States

Founded in 2008





Key Executives for Exosome Diagnostics, Inc.

Chief Executive Officer and President
Chief Financial Officer
Age: 45
Chief Science Officer and Founding Scientist
Head of Informatics
Vice President of Business Development
Compensation as of Fiscal Year 2016.

Exosome Diagnostics, Inc. Key Developments

Exosome Diagnostics, Inc. Enters into a Collaboration with Takeda Pharmaceuticals International Co

Exosome Diagnostics, Inc. has entered into a collaboration with Takeda Pharmaceuticals International Co. to develop an exosomal RNA sequencing platform for biomarkers. As part of the agreement, Exosome Diagnostics will establish a gene expression pipeline with Takeda that will utilize its exosomal RNA isolation technology, RNA-Seq biomarker discovery platform, proprietary algorithms, signal enhancement technology, and additional ancillary technologies for analysis of exosomal RNA. The goal of the pipeline is to develop a platform for serial analysis of gene expression patterns in patients with cancer, as well as additional disease states beyond oncology.

Exosome Diagnostics, Inc. Appoints Mario Morken as Director of Business Development

Exosome Diagnostics, Inc. announced the appointment of Mario Morken as Director of Business Development. Prior to joining Exosome Diagnostics, Mario served as a Senior Product Manager at Bio-Rad Laboratories where he was responsible for their next generation sequencing product.

Exosome Diagnostics, Inc. Announces Key Appointments to Informatics Group

Exosome Diagnostics, Inc. announced that Vasisht Tadigotla has been appointed as Head of Informatics and Robert Kitchen as Senior Scientist, Informatics. Prior to joining Exosome Diagnostics, Vasisht was a Senior Scientist at Courtagen Life Sciences.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
August 31, 2015

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Exosome Diagnostics, Inc., please visit www.exosomedx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.